SOURCE: Healtheuniverse, Inc.

February 22, 2006 09:30 ET

Healtheuniverse Reports Fourth Quarter and Year End Results; Reports Second Straight Profitable Quarter and Exponential Year-Over-Year Top Line and Bottom Line Growth

COVINA, CA -- (MARKET WIRE) -- February 22, 2006 --Healtheuniverse Inc. (OTC: HLUN), a diversified biotechnology development firm specializing in the development and commercialization of patented biopharmaceutical and biomedical products reported financial results for the fourth quarter and year ended December 31, 2005. The company reported net income for the quarter of $32,377, resulting in the company's second straight profitable quarter. Total revenue for the quarter was $148,667, compared to $0 in the fourth quarter of 2004.

For the twelve months ended December 31, 2005, the company reported a net profit of $88,289, which compared to a net loss of $5,921 in 2004. Total revenue for the year ended December 31, 2005 was $524,509, compared to $0 for the year ended December 31, 2004.

Dr. Vipul Dev MD, Chief Executive Officer of Healtheuniverse, Inc. stated, "We are very pleased to show continued strong results in revenue growth and profitability. Our profitability and cash flow in the 4th quarter and for 2005 was particularly gratifying given significant new efforts in both R&D and clinical trial planning as we build for future quarters. Healtheuniverse is positioned to be the leading provider of adult stem cell therapies to the plastic, cosmetic, and reconstructive surgery market and we look forward to transforming these technologies to top line and bottom line results."


HEALTHeUNIVERSE Inc. is a biotechnology development firm specializing in the development and commercialization of patented Biopharmaceutical and Biomedical products. We are engaged in research and development of regenerative medicine therapies using non-embryonic adult stem cells for use in plastic, reconstructive, orthopedic, vascular, and cardiac surgery. Healtheuniverse strives to be the first to commercialize the use of regenerative medicine in plastic and reconstructive surgery and to develop therapeutic uses in the most profitable commercial applications. More information on Healtheuniverse is available online at

Safe Harbor Statement

This press release contains statements, which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of Healtheuniverse Inc., and members of their management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully and the ability to complete before-mentioned transactions. The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.

Contact Information

  • For more information, please contact:
    Healtheuniverse, Inc.
    Investor Relations
    Email Contact